Septic arthritis or adult-onset still's disease: analyzing the causes of recurrent fever after arthroscopic combined anterior cruciate ligament and posterior cruciate ligament reconstruction: a case report. [PDF]
Tian Z +11 more
europepmc +1 more source
Disease‐specific mortality statistics are useful measures of disease burden. Population‐based studies from a few United States counties have reported mortality in systemic autoimmune diseases (SAID). However, due to substantial differences in the population structure of these counties as well as relatively small numbers of SAID deaths in these counties,
Ram Raj Singh
wiley +1 more source
Epidemiological Trends in Pediatric Osteoarticular Infections-Results from a Single-Center Retrospective Study Covering 2015-2023. [PDF]
van Kempen EB +4 more
europepmc +1 more source
Therapeutic drug monitoring education: The current state
Aims To evaluate available information on therapeutic drug monitoring (TDM) education programmes and their implementation across different countries. Methods The study was performed in two phases. First, a scoping review of scientific literature on available education programmes was performed.
Guenka Petrova +10 more
wiley +1 more source
Rapid Diagnosis of Group A Streptococcal Septic Arthritis of the Knees in the Emergency Department Using Point-of-Care Gram Staining of the Synovial Fluid. [PDF]
Taniguchi T +3 more
europepmc +1 more source
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma
Aims Inhaled corticosteroids (ICS) plus bronchodilator are recommended for the treatment of asthma. Targeting the JAK1‐dependent pathway may be an alternative for asthma management in patients with incomplete response to ICS. The aim of this study was to investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of AZD0449, a
Anna Lundahl +11 more
wiley +1 more source
Acute Pyogenic Ankle Monoarthritis Due to Tuberculosis: A Real-Life Clinical Conundrum. [PDF]
Ali O +4 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source

